Varaico: Literature-Extracted Genetic Variants

Gene:CASR
Variant:p.F788C
Back to variants list

CASR

NM_000388.4:p.F788C

Associated Papers

A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemia.

Chang JB et al.

American Journal of Human Genetics, 2025

40664210 (PubMed )
Supplement: mmc1.pdf

Seizures due to Autosomal Dominant Hypocalcemia-Type 1.

Raha SJ et al.

Indian Journal of Pediatrics, 2025

CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants.

Charoenngam N et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Autosomal Dominant Hypocalcemia Type 1 and Neonatal Focal Seizures.

Teleanu RI et al.

Children (basel, Switzerland), 2023

Autosomal Dominant Hypocalcemia Type 1 (ADH1) Associated With Myoclonus and Intracerebral Calcifications.

Elston MS et al.

Journal of the Endocrine Society, 2022

Genetic Screening in a Large Chinese Cohort of Childhood Onset Hypoparathyroidism by Next-Generation Sequencing Combined with TBX1-MLPA.

Wang Y et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2019

Novel mutations associated with inherited human calcium-sensing receptor disorders: A clinical genetic study.

García-Castaño A et al.

European Journal of Endocrinology, 2019

Intractable Generalized Epilepsy and Autosomal Dominant Hypocalcemia: A Case Report.

Rossi GC et al.

Child Neurology Open, 2019

Diagnostic strategy for inherited hypomagnesemia.

Horinouchi T et al.

Clinical and Experimental Nephrology, 2017

Diseases associated with calcium-sensing receptor.

Vahe C et al.

Orphanet Journal of Rare Diseases, 2017

Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis.

Hannan FM et al.

Journal of Molecular Endocrinology, 2016

GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.

Mayr B et al.

European Journal of Endocrinology, 2016

Pathogenesis of hypokalemia in autosomal dominant hypocalcemia type 1.

Kamiyoshi N et al.

Clinical and Experimental Nephrology, 2016

Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.

Cvicek V et al.

Plos Computational Biology, 2016

Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia.

Baran N et al.

Molecular and Cellular Endocrinology, 2015

Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review.

Thim SB et al.

Acta Paediatrica (oslo, Norway : 1992), 2014

Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.

Kinoshita Y et al.

The Journal of Clinical Endocrinology and Metabolism, 2014

Loss-of-function and gain-of-function mutations of calcium-sensing receptor: functional analysis and the effect of allosteric modulators NPS R-568 and NPS 2143.

Nakamura A et al.

The Journal of Clinical Endocrinology and Metabolism, 2013

Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants.

White E et al.

Molecular Endocrinology (baltimore, Md.), 2009

Activation switch in the transmembrane domain of metabotropic glutamate receptor.

Yanagawa M et al.

Molecular Pharmacology, 2009

Inherited disorders of calcium homeostasis.

Ramasamy I

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2008

Severe hypocalcemia due to a de novo mutation in the fifth transmembrane domain of the calcium-sensing receptor.

Mora S et al.

American Journal of Medical Genetics. Part A, 2006

Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.

Tang CM et al.

Expert Opinion on Therapeutic Targets, 2005

A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+.

Hu J et al.

The Journal of Biological Chemistry, 2005

A novel gain-of-function mutation (F821L) in the transmembrane domain of calcium-sensing receptor is a cause of severe sporadic hypoparathyroidism.

Shiohara M et al.

European Journal of Pediatrics, 2004

Recurrent familial hypocalcemia due to germline mosaicism for an activating mutation of the calcium-sensing receptor gene.

Hendy GN et al.

The Journal of Clinical Endocrinology and Metabolism, 2003

Identification of acidic residues in the extracellular loops of the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+ and a positive allosteric modulator.

Hu J et al.

The Journal of Biological Chemistry, 2002

Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.

Sato K et al.

The Journal of Clinical Endocrinology and Metabolism, 2002

[Activating mutations of calcium-sensing receptor cause insufficient secretion of parathyroid hormone].

Fukumoto S

Clinical Calcium, 2001

Activating mutations of the calcium-sensing receptor: management of hypocalcemia.

Lienhardt A et al.

The Journal of Clinical Endocrinology and Metabolism, 2001

A novel mutation in Ca2+-sensing receptor gene in familial hypocalciuric hypercalcemia.

Nakayama T et al.

Endocrine, 2001

Extracellular calcium-sensing receptor: structural and functional features and association with diseases.

Hauache OM

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologica, 2001

Functional importance of the Ala(116)-Pro(136) region in the calcium-sensing receptor. Constitutive activity and inverse agonism in a family C G-protein-coupled receptor.

Jensen AA et al.

The Journal of Biological Chemistry, 2000

Human Ca2+ receptor cysteine-rich domain. Analysis of function of mutant and chimeric receptors.

Hu J et al.

The Journal of Biological Chemistry, 2000

A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia.

Lienhardt A et al.

The Journal of Clinical Endocrinology and Metabolism, 2000

A missense mutation in the seventh transmembrane domain constitutively activates the human Ca2+ receptor.

Zhao XM et al.

Febs Letters, 1999

A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.

Okazaki R et al.

The Journal of Clinical Endocrinology and Metabolism, 1999

Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.

Watanabe T et al.

The Journal of Clinical Endocrinology and Metabolism, 1998

Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators.

Hu J et al.

Journal of Cellular and Molecular Medicine, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."